^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

BT1718

i
Other names: BT1718, BT-1718, BT 1718, MMP14-DM1 peptide drug conjugate
Associations
Company:
Bicycle Therap
Drug class:
Microtubule inhibitor, MMP-14 inhibitor
Related drugs:
Associations
10ms
CRUKD/17/009: BT1718 in Patients With Advanced Solid Tumours. (clinicaltrials.gov)
P1/2, N=72, Completed, Cancer Research UK | Active, not recruiting --> Completed
Trial completion
|
MMP14 (Matrix Metallopeptidase 14)
|
BT1718
over1year
CRUKD/17/009: BT1718 in Patients With Advanced Solid Tumours. (clinicaltrials.gov)
P1/2, N=72, Active, not recruiting, Cancer Research UK | Recruiting --> Active, not recruiting | N=130 --> 72
Enrollment closed • Enrollment change • Metastases
|
MMP14 (Matrix Metallopeptidase 14)
|
BT1718
over2years
CRUKD/17/009: BT1718 in Patients With Advanced Solid Tumours. (clinicaltrials.gov)
P1/2, N=130, Recruiting, Cancer Research UK | Trial completion date: Mar 2022 --> Dec 2024 | Trial primary completion date: Mar 2022 --> Dec 2024
Trial completion date • Trial primary completion date
|
MMP14 (Matrix Metallopeptidase 14)
|
BT1718